Bisphosphonates suppress the breakdown of bone, which improves bone density. They were first used to treat osteoporosis and later noted to help with bone metastases. Bisphosphonates are also approved ...

Zoledronic acid is a potent, new-generation bisphosphonate indicated for the treatment of documented bone metastasis in patients with solid tumors and bone lesions associated with multiple myeloma.

Initial data suggests clodronate (clodronic acid) reduces the incidence of both osseous and visceral metastases in high-risk patients with breast cancer. In addition, like other bisphosphonates ...

How Breast Cancer Cells Survive in Bone Marrow After Remission Dec. 4, 2024 — A new study has shed light on a previously poorly understood aspect of breast cancer recurrence: how cancer cells ...

After hours: December 31 at 6:26:24 PM EST Loading Chart for SIBN ...

This makes it possible to analyse molecular changes caused by tumours, whether primary or metastatic, as well as injuries such as a traumatic brain injury. The molecular flashlight is a probe less ...

Nov. 5, 2024 — Researchers employed analysis tools and machine learning algorithms to identify two genes linked to rheumatoid arthritis and osteoporosis that could serve as diagnostic tools and ...

In 2015, a person with metastatic melanoma — a form of skin cancer that has spread throughout the body — was unlikely to survive more than six months, and possibly not even six weeks if he or ...